Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
JCI Insight|November 19, 2020
A soluble activator that favors the ex vivo expansion of CD8+CD27+ T cellsEsther I Matus, Amanda Sparkes, Jean GariépyCellular Immunology|August 7, 2022
VISTA as a ligand downregulates LPS-mediated inflammation in macrophages and neutrophilsYu-Heng Vivian Ma, Amanda Sparkes, Shrayasee Saha, et al.Scientific Reports|March 22, 2023
The IgV domain of the poliovirus receptor alone is immunosuppressive and binds to its receptors with comparable affinityShrayasee Saha, Amanda Sparkes, Esther I Matus, et al.Mabs|November 24, 2021
Agonistic nanobodies and antibodies to human VISTAYu-Heng Vivian Ma, Amanda Sparkes, Ema Romão, et al.Scientific Reports|November 27, 2025
Human MAdCAM-1 antibodies as targeted immune modulatorsAmanda Sparkes, Esther I Matus, Juan Diego Sanchez Vasquez, et al.ACS Pharmacology & Translational Science|June 20, 2024
Broadly Applicable Bispecific Linker Approach to Noncovalently Target Therapeutic Nanoparticles to Tumor Cells Expressing Carcinoembryonic AntigenAnn Fernando, Amanda Sparkes, Esther I Matus, et al.Immunobiology|May 30, 2017
Reprint of: The non-mammalian MIF superfamilyAmanda Sparkes, Patrick De Baetselier, Kim Roelants, et al.Immunobiology|October 27, 2016
The non-mammalian MIF superfamilyAmanda Sparkes, Patrick De Baetselier, Kim Roelants, et al.Molecular Therapy. Nucleic Acids|September 10, 2018
A Synthetic Cross-Species CD200R1 Agonist Suppresses Inflammatory Immune Responses In VivoAaron Prodeus, Amanda Sparkes, Nicholas W Fischer, et al.Immunobiology|December 3, 2014
Monitoring liver macrophages using nanobodies targeting Vsig4: concanavalin A induced acute hepatitis as paradigmFang Zheng, Nick Devoogdt, Amanda Sparkes, et al.Pageof 2